DR-TB and PMDT

Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up​

Pre-treatment Evaluation [PTE] of DR-TB Patients​

 Components of Drug Resistant TB Counselling Tool

Doses and duration of treatment with Delamanid

Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment​

Bedaquiline Drug Dosages and Duration

Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment​

Drugs Used in the Management of Adverse Events

Guidelines for Issuing Bedaquiline and Delamanid to the Patient

Constituents of Patient-wise Boxes [PWB] for Isoniazid [H] Mono/Poly DR-TB Regimen